Correlation of health-related quality of life with virological response and early treatment discontinuation in patients treated with pegylated (40 kDa) interferon alfa-2a (PEGASYS®) compared with standard interferon alfa-2a.

被引：0
|
作者：
Bernstein, DE
Cooksley, G
Fried, MW
Heathcote, JE
Pockros, PJ
Zeuzem, S
Marinos, G
Rustgi, V
Revicki, D
Barker, CM
Green, J
机构：
[1] N Shore Univ Hosp, Manhasset, NY USA
[2] Royal Brisbane Hosp, Herston, Qld, Australia
[3] Univ N Carolina, Chapel Hill, NC 27515 USA
[4] Univ Toronto, Toronto, ON, Canada
[5] Scripps Clin, La Jolla, CA USA
[6] Univ Hosp, Frankfurt, Germany
[7] Prince Wales Hosp, Randwick, NSW 2031, Australia
[8] Georgetown Univ, Med Ctr, Fairfax, VA USA
[9] MEDTAP Int Inc, Bethesda, MD USA
[10] Hoffmann La Roche Inc, Nutley, NJ 07110 USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1958
引用
收藏
页码：A382 / A382
页数：1
相关论文
共 50 条
  • [21] Clinical utility of HCV RNA quantification using the COBAS AMPLICOR HCV MONITOR™ Test, version 2.0, as an early predictor of sustained response to interferon alfa-2a (Roferon-A®) or pegylated (40KDA) interferon alfa-2a (Pegasys™) therapy.
    Shiffman, ML
    Wright, TL
    Pockros, PJ
    Reddy, RK
    Reindollar, RW
    Everson, GT
    Fried, MW
    Fine, F
    Murray, A
    Gutekunst, K
    DePamphilis, J
    [J]. HEPATOLOGY, 2000, 32 (04) : 360A - 360A
  • [22] Treatment with pegylated interferon alfa-2b in combination with ribavirin improved health-related quality of life compared with interferon alfa-2b plus ribavirin in chronic hepatitis C.
    Gish, R
    Rzowej, N
    Brooks, L
    Brass, C
    Weng, W
    [J]. HEPATOLOGY, 2002, 36 (04) : 582A - 582A
  • [23] Long-lasting sustained virological response in chronic hepatitis C patients previously treated with 40 kDa peginterferon alfa-2a (PEGASYS®).
    Swain, M
    Heathcote, EJ
    Lai, MY
    Bain, V
    Feinman, V
    Sherman, M
    Kaita, KD
    Gane, E
    Peltekian, K
    Lindsay, K
    Hoffman, J
    Brunda, M
    [J]. HEPATOLOGY, 2001, 34 (04) : 330A - 330A
  • [24] Tolerability of 40 kDa peginterferon alfa-2a (PEGASYS®) versus standard interferon alfa-2b/ribavirin combination therapy (IFN/RBV) in patients with chronic hepatitis C (CHC).
    Perrillo, RP
    Rothstein, KD
    Thuluvath, PJ
    Alam, L
    Doerschuk, B
    Wynohradnyk, L
    Pappas, SC
    [J]. HEPATOLOGY, 2001, 34 (04) : 327A - 327A
  • [25] Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin in Pakistan
    Gill, Uzma
    Aziz, Hafsa
    Gill, Muzaffar Lateef
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (11) : E1017 - E1021
  • [26] Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
    Moucari, Rami
    Mackiewicz, Vincent
    Lada, Olivier
    Ripault, Marie-Pierre
    Castelnau, Corinne
    Martinot-Peignoux, Michelle
    Dauvergne, Agnes
    Asselah, Tarik
    Boyer, Nathalie
    Bedossa, Pierre
    Valla, Dominique
    Vidaud, Michel
    Nicolas-Chanoine, Marie-Helene
    Marcellin, Patrick
    [J]. HEPATOLOGY, 2009, 49 (04) : 1151 - 1157
  • [27] The impact of pegylated interferon alfa-2b on health-related quality of life in chronic hepatitis C patients.
    Feagan, BG
    Trepo, C
    Lindsay, KL
    Niederau, C
    Wong, CJ
    Weng, CSW
    Albrecht, JK
    [J]. HEPATOLOGY, 2000, 32 (04) : 307A - 307A
  • [28] Pegylated (40kDa) interferon alfa-2A (Pegasys™) in new combination therapies:: A preliminary report of a randomized, multicenter efficacy and safety study.
    Di Bisceglie, AM
    Bernstein, DE
    Rustgi, VR
    Gitlin, N
    Jeffers, LJ
    Simon, D
    Pappas, SC
    Campagna, J
    [J]. HEPATOLOGY, 2000, 32 (04) : 444A - 444A
  • [29] Durability of Response in Children Treated With Pegylated Interferon alfa-2a ± Ribavirin for Chronic Hepatitis C
    Schwarz, Kathleen B.
    Molleston, Jean P.
    Jonas, Maureen M.
    Wen, Jessica
    Murray, Karen F.
    Rosenthal, Philip
    Gonzalez-Peralta, Regino P.
    Lobritto, Steven J.
    Mogul, Douglas
    Pavlovic, Vedran
    Warne, Charles
    Wat, Cynthia
    Thompson, Bruce
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2016, 62 (01): : 93 - 96
  • [30] Pegylated interferon alfa-2a (40 kD) and ribavirin in haemodialysis patients with chronic hepatitis C
    van Leusen, Robert
    Adang, Rob P. R.
    de Vries, Richard A.
    Cnossen, Trijntje T.
    Konings, Constantijn J. A. M.
    Schalm, Solko W.
    Tan, Adriaan C. I. T. L.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (02) : 721 - 725
12345